tradingkey.logo
tradingkey.logo
Suchen

Kestra Medical Technologies Ltd

KMTS
Zur Watchlist hinzufügen
26.781USD
+0.501+1.91%
Trading geöffnet ETKurse um 15 Minuten verzögert
1.56BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Kestra Medical Technologies Ltd Unternehmen

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Kestra Medical Technologies Ltd Informationen

BörsenkürzelKMTS
Name des UnternehmensKestra Medical Technologies Ltd
IPO-datumMar 06, 2025
CEOWebster (Brian Daniel)
Anzahl der mitarbeiter330
WertpapierartOrdinary Share
GeschäftsjahresendeMar 06
Addresse3933 Lake Washington Blvd Ne
StadtKIRKLAND
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl98033
Telefon14252798002
Website
BörsenkürzelKMTS
IPO-datumMar 06, 2025
CEOWebster (Brian Daniel)

Führungskräfte von Kestra Medical Technologies Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
280.02K
+21.67%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
119.65K
+21.08%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
40.06K
+62.97%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Mr. Al Ford
Mr. Al Ford
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jeffrey Schwartz
Mr. Jeffrey Schwartz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Toby AuWerter
Mr. Toby AuWerter
Independent Director
Independent Director
--
--
Mr. Maxwell Bikoff
Mr. Maxwell Bikoff
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
280.02K
+21.67%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
119.65K
+21.08%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
40.06K
+62.97%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Kestra Medical Technologies Ltd?

Die fünf größten Anteilseigner von Kestra Medical Technologies Ltd sind: Mr. Brian Webster

Wie viele Institutionen halten Anteile an Kestra Medical Technologies Ltd (KMTS)?

Mit Stand vom 2026Q1 halten 218 Institutionen Anteile an Kestra Medical Technologies Ltd, mit einem Gesamtmarktwert von etwa 60.76M, was 104.08% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 5705735.00 gestiegen.